Cours pSivida Corp. Nasdaq

Actions

09/08/16	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle
14/07/16	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve
02/05/16	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe
28/09/15	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs
14/09/15	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015

1 jour

-0,87%

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	Varia.	Varia. 5j.	Varia. 1an	Varia. 3ans	Capi.($)
PSIVIDA CORP.	-0,87%	-2,40%	-	-	0
WUXI APPTEC CO., LTD.	-0,70%	-4,28%	+52,62%	+86,42%	71,81 Md
ARGENX SE	+0,45%	-0,82%	+38,81%	+84,19%	60,06 Md
WUXI BIOLOGICS (CAYMAN) INC.	0,00%	+1,33%	+30,55%	+20,36%	27,93 Md
INSMED INCORPORATED	-1,73%	-4,30%	-18,37%	+357,94%	25,7 Md
BIONTECH SE	-0,51%	-2,28%	+0,48%	-9,27%	24,89 Md
GENMAB A/S	+0,65%	+1,67%	+26,47%	-7,62%	20,92 Md
PHARMAESSENTIA CORPORATION	+3,46%	+3,02%	+158,90%	+337,81%	15,04 Md
EXELIXIS, INC.	+0,48%	+0,86%	+44,56%	+168,42%	14,46 Md
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+3,91%	-3,51%	-4,56%	+517,49%	13,87 Md
Moyenne	+0,51%	-1,38%	+36,61%	+172,86%	30,52 Md
Moyenne pondérée par Capi.	+0,17%	-1,84%	+36,51%	+128,64%